|
|
| Product N° |
Productname |
Quantity |
Price (EUR) |
Tech sheet |
|
|
TXL6091-100
|
(-)-Scopolamine Perchlorate (Hyoscine perchlorate)
|
100 mg.
|
139
|
|
|
|
TXL6091-500
|
(-)-Scopolamine Perchlorate (Hyoscine perchlorate)
|
500 mg.
|
464
|
|
|
|
TXL6016-100
|
(d,l)-Tetrahydroberberine (Canadine)
|
100 mg.
|
1.093
|
|
|
|
TXL6016-20
|
(d,l)-Tetrahydroberberine (Canadine)
|
20 mg.
|
297
|
|
|
|
TXL6038-25
|
(d,l)-Tetrahyrdopalmatine Hydrochloride
|
25 mg.
|
900
|
|
|
|
TXL6038-5
|
(d,l)-Tetrahyrdopalmatine Hydrochloride
|
5 mg.
|
247
|
|
|
|
BMAT4602
|
(Tyr1)-Adipokinetic Hormone I, Rabbit anti-Locusta migratoria
|
400 µg.
|
1.044
|
|
|
|
BMAS3155
|
(Tyr1)-Adipokinetic Hormone I, Rabbit anti-Locusta migratoria, IF Kit
|
kit
|
70.230
|
|
|
|
BMAT4585
|
(Tyr1)-Adipokinetic Hormone I, Rabbit anti-Locusta migratoria; IH
|
50 µl.
|
576
|
|
|
|
BMAT4592
|
(Tyr1)-Adipokinetic Hormone I, Rabbit anti-Locusta migratoria; RIA
|
vial
|
1.122
|
|
|
|
TXL8206-250
|
[Tyr2] Scyllatoxin ([Tyr2] Leiurotoxin I)
|
5x50 µg.
|
2.318
|
|
|
|
TXL8206-50
|
[Tyr2] Scyllatoxin ([Tyr2] Leiurotoxin I)
|
50 µg.
|
602
|
|
|
|
B350/1
|
±Bay K 8644 (±enantiomer), 356.3MW, L-type Voltage-Gated Ca2+ (Cav 1 family) Channel Agonist/Activator
|
1 mg.
|
12.250
|
|
|
|
B350/25
|
±Bay K 8644 (±enantiomer), 356.3MW, L-type Voltage-Gated Ca2+ (Cav 1 family) Channel Agonist/Activator
|
5x5 mg.
|
78.030
|
|
|
|
B350/5
|
±Bay K 8644 (±enantiomer), 356.3MW, L-type Voltage-Gated Ca2+ (Cav 1 family) Channel Agonist/Activator
|
5 mg.
|
19.530
|
|
|
|
ACLPRO363
|
µ-Calpain
|
2 µg.
|
30.000
|
|
|
|
ACLPRO363B
|
µ-Calpain
|
5 µg.
|
30.000
|
|
|
|
C270/1
|
µ-Conotoxin GIIIB (Conus geographus), Voltage-Gated Na+ Channel Blocker of skeletal muscle VGSC, 2.640kD
|
0.1 mg.
|
438
|
|
|
|
TXL6206-50
|
14-Acetylvirescenine
|
50 mg.
|
716
|
|
|
|
ABA1064
|
17 Alpha-Hydroxyprogesterone-3-OCMO, Donkey anti-
|
vial
|
30.000
|
|
|
|
YSGKAMCC014E
|
14-3-3β, 30kD, Clone: 4E1, Mab anti-Mouse, Rat; WB/IP
|
100 µg.
|
797
|
|
|
|
BYA5024-1a
|
17 Alpha-Hydroxyprogesterone-7-BSA, Rabbit anti-
|
vial
|
1.065
|
|
|
|
BYA5024-1
|
17 Alpha-Hydroxyprogesterone-7-BSA, Rabbit anti-
|
vial
|
222
|
|
|
|
YBG78351109
|
14-3-3 Protein, Human, 98% pure
|
5 µg.
|
203
|
|
|
|
YGUYS025
|
11 Deoxycortisol, Sheep anti-
|
1 mg.
|
440
|
|
|
|
BYA5524-1
|
17 Alpha-Hydroxyprogesterone-7-BSA, Rabbit anti-
|
1 ml.
|
30.000
|
|
|
|
YLH1002
|
17 Alpha-Hydroxyprogesterone, Rabbit anti-
|
vial
|
15.500
|
|
|
|
YSGKAMCC012C
|
14-3-3β/ζ, ~29-30kD, Clone: 22-ii-D8B, Mab anti-Human, Mouse, Rat, Monkey, Dog, Sheep, Swine, Bovine; WB/IH/IC
|
25 µg.
|
389
|
|
|
|
C270/5
|
µ-Conotoxin GIIIB (Conus geographus), Voltage-Gated Na+ Channel Blocker of skeletal muscle VGSC, 2.640kD
|
5x0.1 mg.
|
1.663
|
|
|
|
UCBA903/R1H
|
17 Alpha-Hydroxyprogesterone, Rabbit anti-, Rabbit anti-; RIA
|
vial
|
536
|
|
|
|
YSGKAMCC013E
|
14-3-3β/ε/ζ, ~30kD, Clone: 3C8, Mab anti-Human, Mouse, Rat; WB
|
100 µg.
|
944
|
|
|
|
UCH1433/1
|
14-3-3 Protein, Human, 98% pure
|
1 mg.
|
30.000
|
|
|
|
YSGKAMCC012E
|
14-3-3β/ζ, ~29-30kD, Clone: 22-ii-D8B, Mab anti-Human, Mouse, Rat, Monkey, Dog, Sheep, Swine, Bovine; WB/IH/IC
|
100 µg.
|
797
|
|
|
|
UCH1433/05
|
14-3-3 Protein, Human, 98% pure
|
5 µg.
|
30.000
|
|
|
|
YGUS085
|
17 Alpha-Hydroxyprogesterone, Sheep anti-
|
1 ml.
|
276
|
|
|
|
ABA1065
|
17 Alpha-Hydroxyprogesterone-3-OCMO, Rabbit anti-
|
vial
|
30.000
|
|
|
|
UCBA915/R1T
|
11 beta Hydroxy delta 4-Androstendione, Rabbit anti-; RIA
|
vial
|
536
|
|
|
|
ABA3020
|
13,14-Dihydro-15-keto-Prostaglandin F2a, Rabbit anti-
|
vial
|
30.000
|
|
|
|
TXL6206-10
|
14-Acetylvirescenine
|
10 mg.
|
202
|
|
|
|
YGUS025-FD
|
11 Deoxycortisol, Sheep anti-
|
0.5 ml.
|
276
|
|
|
|
YGUS025
|
11 Deoxycortisol, Sheep anti-
|
1 ml.
|
276
|
|
|
|
ABA3010
|
13,14-Dihydro-15-keto-Prostaglandin E2, Rabbit anti-
|
vial
|
30.000
|
|
|
|
UCBA913/R1T
|
11-Desoxycorticosterone, Rabbit anti-; RIA
|
vial
|
536
|
|
|
|
ICCA52
|
17 Hydroxyprogesterone 3-CMO-BSA, Rabbit anti-; RIA
|
vial
|
47.740
|
|
|
|
A580/5
|
17-AAG (17-(Allylamino)-17-demethoxygeldanamycin), Geldanamycin derivative, 0.5857kD
|
5x0.1 mg.
|
761
|
|
|
|
BYA5024-4
|
17 Alpha-Hydroxyprogesterone-7-BSA, Rabbit anti-
|
vial
|
5.746
|
|
|
|
ABASYN-0009
|
17 Alpha-Hydroxyprogesterone-3-OCMO
|
10 mg.
|
30.000
|
|
|
|
A580/1
|
17-AAG (17-(Allylamino)-17-demethoxygeldanamycin), Geldanamycin derivative, 0.5857kD
|
0.1 mg.
|
217
|
|
|
|
YMCAS0112
|
17 Hydroxyprogesterone (7-Thioproprionate-BSA), Rabbit anti-Human
|
vial
|
33.960
|
|
|
|
YMCAS0132
|
17 Hydroxypregnenolone (3ß-hemisuccinate-BSA), 17-OH-Progesterone (30% x rxn), Rabbit anti-Human
|
vial
|
33.960
|
|
|